Author Archives: syoligo

Sylentis, a PharmaMar Group company, will receive €21.1 million from the NextGenerationEU fund for research into rare diseases and the construction of a manufacturing plant

Sylentis, a PharmaMar Group (MSE:PHM) company, announces that the European Commission has today made public the Decision C(2024) 3629 final of May 28th  2024, by which the Company has been